ACQUISITION OF CUREDM (Tables)

3 Months Ended

Mar. 31, 2019

Acquisition Of Curedm

Schedule of consideration

A summary of consideration is as follows:

25,000,000 shares of the Company’s common stock	$	1,250,000
22,741,140 contingency shares of the Company’s common stock		—
Total consideration	$	1,250,000

Schedule of fair value of assets acquired and liabilities assumed

The following summarizes the current estimates of fair value of assets acquired and liabilities assumed:

Assets acquired:
Cash	$	3,592
Property and equipment		273
Goodwill		1,176,220
Intangibles		234,122
Liabilities assumed:
Accounts payable and accrued expenses		(164,207	)
Net assets acquired	$	1,250,000

Schedule of pro forma results

These combined results are not necessarily indicative of the results that may have been achieved had the companies been combined as of the first day of the period presented.

	Three months ended,  March 31, 2019			Three months ended,  March 31, 2018
Total revenues	$	4,085		$	9,236
Net loss	$	(951,880	)	$	(2,743,206	)
Basic and diluted net earnings per common share	$	(0.01	)	$	(0.03	)